TY - JOUR
T1 - A Systematic Review and Meta-Analysis of Patient Decision Aids for Socially Disadvantaged Populations
T2 - Update from the International Patient Decision Aid Standards (IDPAS)
AU - Yen, Renata W.
AU - Smith, Jenna
AU - Engel, Jaclyn
AU - Muscat, Danielle Marie
AU - Smith, Sian K.
AU - Mancini, Julien
AU - Perestelo-Pérez, Lilisbeth
AU - Elwyn, Glyn
AU - O’Malley, A. James
AU - Leyenaar, Jo Anna K.
AU - Mac, Olivia
AU - Cadet, Tamara
AU - Giguere, Anik
AU - Housten, Ashley J.
AU - Langford, Aisha
AU - McCaffery, Kirsten
AU - Durand, Marie Anne
N1 - Publisher Copyright:
© The Author(s) 2021.
PY - 2021/10
Y1 - 2021/10
N2 - Background: The effectiveness of patient decision aids (PtDAs) and other shared decision-making (SDM) interventions for socially disadvantaged populations has not been well studied. Purpose: To assess whether PtDAs and other SDM interventions improve outcomes or decrease health inequalities among socially disadvantaged populations and determine the critical features of successful interventions. Data Sources: MEDLINE, CINAHL, Cochrane, PsycINFO, and Web of Science from inception to October 2019. Cochrane systematic reviews on PtDAs. Study Selection: Randomized controlled trials of PtDAs and SDM interventions that included socially disadvantaged populations. Data Extraction: Independent double data extraction using a standardized form and the Template for Intervention Description and Replication checklist. Data Synthesis: Twenty-five PtDA and 13 other SDM intervention trials met our inclusion criteria. Compared with usual care, PtDAs improved knowledge (mean difference = 13.91, 95% confidence interval [CI] 9.01, 18.82 [I2 = 96%]) and patient-clinician communication (relative risk = 1.62, 95% CI 1.42, 1.84 [I2 = 0%]). PtDAs reduced decisional conflict (mean difference = −9.59; 95% CI −18.94, −0.24 [I2 = 84%]) and the proportion undecided (relative risk = 0.39; 95% CI 0.28, 0.53 [I2 = 75%]). PtDAs did not affect anxiety (standardized mean difference = 0.02, 95% CI −0.22, 0.26 [I2 = 70%]). Only 1 trial looked at clinical outcomes (hemoglobin A1C). Five of the 12 PtDA studies that compared outcomes by disadvantaged standing found that outcomes improved more for socially disadvantaged participants. No evidence indicated which intervention characteristics were most effective. Results were similar for SDM intervention trials. Limitations: Sixteen PtDA studies had an overall unclear risk of bias. Heterogeneity was high for most outcomes. Most studies only had short-term follow-up. Conclusions: PtDAs led to better outcomes among socially disadvantaged populations but did not reduce health inequalities. We could not determine which intervention features were most effective. Systematic review and meta-analysis of patient decision aids and other shared decision-making (SDM) interventions for disadvantaged populations. Patient decision aids and other SDM interventions improve patient-reported outcomes for disadvantaged populations. There was no evidence on what intervention characteristics best supported disadvantaged populations.
AB - Background: The effectiveness of patient decision aids (PtDAs) and other shared decision-making (SDM) interventions for socially disadvantaged populations has not been well studied. Purpose: To assess whether PtDAs and other SDM interventions improve outcomes or decrease health inequalities among socially disadvantaged populations and determine the critical features of successful interventions. Data Sources: MEDLINE, CINAHL, Cochrane, PsycINFO, and Web of Science from inception to October 2019. Cochrane systematic reviews on PtDAs. Study Selection: Randomized controlled trials of PtDAs and SDM interventions that included socially disadvantaged populations. Data Extraction: Independent double data extraction using a standardized form and the Template for Intervention Description and Replication checklist. Data Synthesis: Twenty-five PtDA and 13 other SDM intervention trials met our inclusion criteria. Compared with usual care, PtDAs improved knowledge (mean difference = 13.91, 95% confidence interval [CI] 9.01, 18.82 [I2 = 96%]) and patient-clinician communication (relative risk = 1.62, 95% CI 1.42, 1.84 [I2 = 0%]). PtDAs reduced decisional conflict (mean difference = −9.59; 95% CI −18.94, −0.24 [I2 = 84%]) and the proportion undecided (relative risk = 0.39; 95% CI 0.28, 0.53 [I2 = 75%]). PtDAs did not affect anxiety (standardized mean difference = 0.02, 95% CI −0.22, 0.26 [I2 = 70%]). Only 1 trial looked at clinical outcomes (hemoglobin A1C). Five of the 12 PtDA studies that compared outcomes by disadvantaged standing found that outcomes improved more for socially disadvantaged participants. No evidence indicated which intervention characteristics were most effective. Results were similar for SDM intervention trials. Limitations: Sixteen PtDA studies had an overall unclear risk of bias. Heterogeneity was high for most outcomes. Most studies only had short-term follow-up. Conclusions: PtDAs led to better outcomes among socially disadvantaged populations but did not reduce health inequalities. We could not determine which intervention features were most effective. Systematic review and meta-analysis of patient decision aids and other shared decision-making (SDM) interventions for disadvantaged populations. Patient decision aids and other SDM interventions improve patient-reported outcomes for disadvantaged populations. There was no evidence on what intervention characteristics best supported disadvantaged populations.
KW - health disparities
KW - health literacy
KW - patient decision aids
KW - patient-provider communication
KW - shared decision making
UR - http://www.scopus.com/inward/record.url?scp=85108814160&partnerID=8YFLogxK
U2 - 10.1177/0272989X211020317
DO - 10.1177/0272989X211020317
M3 - Review article
C2 - 34151614
AN - SCOPUS:85108814160
SN - 0272-989X
VL - 41
SP - 870
EP - 896
JO - Medical Decision Making
JF - Medical Decision Making
IS - 7
ER -